GlassScriptPhysician profile
Ashley B Davidson
NPI 1457481947
$5,988.12
in general payments reported to CMS, 2019-2025
54 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $485 · 2021: $611 · 2022: $774 · 2023: $874 · 2024: $1,149 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169 · Education: $35.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.28 |
| Education | $35.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $667.88 | 2019-2025 | |
| Amgen INC. | $490.29 | 2019-2025 | Evenity, Prolia, Tepezza |
| Abbvie INC. | $460.55 | 2019-2025 | Synthroid |
| Novo Nordisk INC | $397.35 | 2019-2025 | Ozempic, Rybelsus, Sogroya |
| Corcept Therapeutics | $385.32 | 2019-2025 | Korlym |
| Tandem Diabetes Care, INC. | $267.67 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $214.53 | 2020-2025 | Tymlos |
| Beta Bionics, INC. | $172.14 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astrazeneca Pharmaceuticals LP | $170.42 | 2019-2023 | Farxiga |
| Amneal Pharmaceuticals LLC | $157.23 | 2020-2025 | Unithroid |
| Abbott Laboratories | $155.29 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $149.78 | 2019-2025 | Omnipod |
| Horizon Therapeutics Plc | $139.91 | 2020-2023 | Tepezza |
| Alexion Pharmaceuticals, INC. | $123.54 | 2022-2025 | Strensiq |
| Lilly USA, LLC | $116.60 | 2019-2025 | Mounjaro, Zepbound |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.